Nalmefene attenuates neural alcohol cue-reactivity in the ventral striatum and subjective alcohol craving in patients with alcohol use disorder
Alcohol use disorder is a common and devastating mental illness for which satisfactory treatments are still lacking. Nalmefene, as an opioid receptor modulator, could pharmacologically support the reduction of drinking by reducing the (anticipated) rewarding effects of alcohol and expanding the rang...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
12 April 2021
|
| In: |
Psychopharmacology
Year: 2021, Volume: 238, Issue: 8, Pages: 2179-2189 |
| ISSN: | 1432-2072 |
| DOI: | 10.1007/s00213-021-05842-7 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00213-021-05842-7 |
| Author Notes: | Damian Karl, J. Malte Bumb, Patrick Bach, Christina Dinter, Anne Koopmann, Derik Hermann, Karl Mann, Falk Kiefer, Sabine Vollstädt-Klein |
| Summary: | Alcohol use disorder is a common and devastating mental illness for which satisfactory treatments are still lacking. Nalmefene, as an opioid receptor modulator, could pharmacologically support the reduction of drinking by reducing the (anticipated) rewarding effects of alcohol and expanding the range of treatment options. It has been hypothesized that nalmefene acts via an indirect modulation of the mesolimbic reward system. So far, only a few imaging findings on the neuronal response to nalmefene are available. |
|---|---|
| Item Description: | Gesehen am 04.01.2023 |
| Physical Description: | Online Resource |
| ISSN: | 1432-2072 |
| DOI: | 10.1007/s00213-021-05842-7 |